|
시장보고서
상품코드
1566355
세포 및 유전자 치료 바이오 분석 검사 서비스 시장 : 규모, 점유율, 동향, 산업 분석 - 검사 유형별, 제품 유형별, 개발 단계별, 질병별, 지역별, 부문별 예측(2024-2032년)Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share, Trends, Industry Analysis Report - By Test Type, By Product Type, By Stage of Development, By Indication, and By Region; Segment Forecast, 2024-2032 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 규모는 2032년까지 9억 5,006만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
세포 치료와 유전자 치료가 여러 질병을 치료할 수 있다는 연구 결과가 늘어나면서 의료업계의 연구 활동에 대한 투자가 증가하고 있습니다. 시장에서는 의약품과 의료기기의 검사 능력을 향상시키기 위해 정부의 자금 지원이 이루어지고 있습니다. 예를 들어, 2023년 3월 영국 정부는 국립보건서비스 혈액 및 이식(NHSBT)이 새로운 세포 및 유전자 치료제의 개발 및 제조를 위한 임상생명공학센터(CBC)라는 새로운 시설을 개설하기 위해 1,000만 달러를 지원한다고 발표했습니다. 또한, 전 세계적으로 암 환자가 증가함에 따라 각국은 세포 및 유전자 치료 연구에 대한 투자에 집중하고 있습니다. 인도와 중국 등 인구가 많은 국가들은 암 치료를 위한 새로운 치료법을 발표하고 있습니다. 예를 들어, 2024년 4월 타타기념센터와 인도공과대학(IIT) 봄베이는 인도에서 최초로 암 치료를 위해 개발된 CAR-T 세포 치료제를 출시했습니다. 이러한 새로운 세포 치료법은 세포 및 유전자 치료 바이오 분석 검사 서비스에 대한 수요를 증가시켜 시장 성장에 기여하고 있습니다.
세포 치료제 및 유전자 치료제 설계 및 생산에 대한 투자를 늘리려는 제약회사들의 노력이 증가하면서 성능 평가 도구 및 서비스에 대한 수요가 증가하고 있으며, 이는 세계 시장에 긍정적인 영향을 미치고 있습니다. 예를 들어, 2024년 2월, Azzur Group은 세포 및 유전자 치료제 개발의 일환으로 새로운 분석 실험실 검사 서비스를 제공한다고 발표했습니다. 이는 특히 첨단 치료제 및 기타 의료 제품을 검사하기 위한 것입니다. 만성 질환의 증가로 인해 연구자들은 효과적인 약물을 개발하기 위해 노력하고 있습니다. 세포 치료와 유전자 치료의 발전으로 사람들의 건강 문제를 효과적으로 치료할 수 있게 되었습니다. 미국 식품의약국(FDA)에 따르면, 겸상적혈구증으로 고통받는 사람이 10만 명에 달한다고 합니다. 2023년 12월, 미국 FDA는 겸상적혈구증 치료제로 라이프제니아와 카스제비라는 두 가지 유전자 치료제를 승인했다고 발표했습니다.
세포 및 유전자 치료 바이오 분석 검사 서비스 시장 보고서 하이라이트
검사 유형별로는 의약품 혁신 활동의 증가로 인해 생체이용률 및 생물학적 동등성 검사 부문이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.
제품 유형별로는 일부 질병에 대한 세포 치료제 생산이 증가함에 따라 세포 치료제 부문이 2023년 가장 큰 시장 점유율을 차지했습니다.
아시아태평양은 생명공학 산업에 대한 투자 증가로 인해 예측 기간 동안 가장 높은 성장률을 기록할 것으로 예상됩니다.
유럽은 첨단 치료 연구에 대한 투자 증가로 인해 예측 기간 동안 세포 및 유전자 치료 바이오 분석 검사 서비스 시장에서 큰 CAGR을 기록할 것으로 예상됩니다.
BioAgilytix Labs, Charles River Laboratories, Intertek Group, IQVIA, KCAS Bioanalytical Services, Pharmaron 등이 세계 시장 기업입니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 인사이트
- 용도 현황
- 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 역학
- 성장 촉진요인과 기회
- 세포 및 유전자 치료 개발에 대한 투자 증가가 시장 성장을 촉진
- 세포 및 유전자 치료 개발 확대가 시장 성장을 견인
- 성장 억제요인과 과제
- 엄격한 규제가 시장 성장을 저해하는
- 성장 촉진요인과 기회
- PESTEL 분석
- 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 용도 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 : 검사 유형별
- 주요 조사 결과
- 소개
- 생체이용률·생물학적 동등성 연구
- 약물동태
- 약력학
- 기타
제6장 세계의 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 : 제품 유형별
- 주요 조사 결과
- 소개
- 유전자 치료
- 유전자 재조합 세포 치료
- 세포 치료
제7장 세계의 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 : 개발 단계별
- 주요 조사 결과
- 소개
- 비임상
- 임상
제8장 세계의 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 : 질환별
- 주요 조사 결과
- 소개
- 감염증
- 신경질환
- 종양학
- 희귀질환
- 기타
제9장 세계의 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 : 지역별
- 주요 조사 결과
- 소개
- 세포 및 유전자 치료 바이오 분석 검사 서비스 시장 평가 : 지역별(2019-2032년)
- 북미
- 북미 : 검사 유형별(2019-2032년)
- 북미 : 제품 유형별(2019-2032년)
- 북미 : 개발 단계별(2019-2032년)
- 북미 : 질환별(2019-2032년)
- 미국
- 캐나다
- 유럽
- 유럽 : 검사 유형별(2019-2032년)
- 유럽 : 제품 유형별(2019-2032년)
- 유럽 : 개발 단계별(2019-2032년)
- 유럽 : 증상별(2019-2032년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 검사 유형별(2019-2032년)
- 아시아태평양 : 제품 유형별(2019-2032년)
- 아시아태평양 : 개발 단계별(2019-2032년)
- 아시아태평양 : 질환별(2019-2032년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 검사 유형별(2019-2032년)
- 중동 및 아프리카 : 제품 유형별(2019-2032년)
- 중동 및 아프리카 : 개발 단계별(2019-2032년)
- 중동 및 아프리카 : 질환별(2019-2032년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 검사 유형별(2019-2032년)
- 라틴아메리카 : 제품 유형별(2019-2032년)
- 라틴아메리카 : 개발 단계별(2019-2032년)
- 라틴아메리카 : 질환별(2019-2032년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 상황
- 사업 확대와 인수 분석
- 사업 확대
- 인수
- 제휴/협업/계약/공개
제11장 기업 개요
- BioAgilytix Labs
- Charles River Laboratories
- Intertek Group Plc.
- IQVIA, Inc.
- KCAS Bioanalytical Services
- Laboratory Corporation of America Holdings
- Pharmaron
- Pharmaceutical Product Development, Inc.
- Prolytix
- SGS SA
- Syneos Health
The cell & gene therapy bioanalytical testing services market size is expected to reach USD 950.06 million by 2032, according to a new study by Polaris Market Research. The report "Cell & Gene Therapy Bioanalytical Testing Services Market Share, Size, Trends, Industry Analysis Report - By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, and Others), By Product Type, By Stage of Development, By Indication, and By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing number of studies revealing the ability of cell and gene therapies to treat multiple diseases is driving investments in research activities in the healthcare industry. The government funding to increase its capacity to test medication and healthcare equipment in the marketplace. For instance, in March 2023, the UK government announced a grant of USD 10 million for the National Health Service Blood and Transplant (NHSBT) to open a new facility called the Clinical Biotechnology Centre (CBC) for the development and manufacturing of new cell and gene therapies. Furthermore, the growing number of cancer cases across the world is significantly emphasizing countries to invest in cell and gene therapy research. The most populous nations, such as India and China, are launching new therapies for the cancer treatment. For instance, in April 2024, Tata Memorial Centre & Indian Institute of Technology (IIT), Bombay launched India's first developed CAR-T cell therapy for cancer treatment. Thus new cell therapy is boosting demand for cell & gene therapy bioanalytical testing services, which is contributing to market growth.
The rising pharmaceutical companies' initiatives to increase investments in the design and production of cell and gene therapies are driving the demand for performance-evaluating tools and services, which is positively influencing the global market. For instance, in February 2024, Azzur Group announced the new offering of analytical laboratory testing services as a part of developing cell and gene therapy. This is specifically to test advanced therapeutics and other medical products. The increasing prevalence of chronic diseases is encouraging researchers to innovate effective medications. The growing development of cell and gene therapies effectively performs in treating health issues among the population. According to the Food and Drug Administration (FDA), ~100,000 people are suffering from sickle cell disease. This contributed to the design of new therapies around the world. In December 2023, the US FDA announced approval for two gene therapies-Lyfgenia & Casgevy-for the treatment of sickle cell disease.
Cell & Gene Therapy Bioanalytical Testing Services Market Report Highlights
The bioavailability & bioequivalence studies segment, by test type is anticipated to witness the highest growth rate during the forecast period due to rising drug innovation activities.
In terms of product type, the cell therapy segment accounted for the largest market share in 2023, owing to the increasing production of cell therapies for several diseases.
APAC is projected to register the highest growth during the forecast period, attributable to the growing investments in the biotechnological industry.
Europe is expected to register a significant CAGR in the cell & gene therapy bioanalytical testing services market during the forecast period due to due increased investment in advanced therapeutic research.
BioAgilytix Labs, Charles River Laboratories, Intertek Group, IQVIA, KCAS Bioanalytical Services, and Pharmaron are among the global market players.
Polaris Market Research has segmented the cell & gene therapy bioanalytical testing services market report on the basis of test type, product type, stage of development, indication, and region:
By Test Type Outlook (Revenue - USD million, 2019-2032)
- Bioavailability & Bioequivalence Studies
- Pharmacokinetics
- Pharmacodynamics
- Others
By Product Type Outlook (Revenue - USD million, 2019-2032)
- Gene Therapy
- Gene-Modified Cell Therapy
- Cell Therapy
By Stage of Development Outlook (Revenue - USD million, 2019-2032)
- Nonclinical
- Clinical
By Indication Outlook (Revenue - USD million, 2019-2032)
- Oncology
- Infectious Diseases
- Neurological Disorders
- Rare Diseases
- Others
By Regional Outlook (Revenue - USD million, 2019-2032)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Cell & Gene Therapy Bioanalytical Testing Services Market Insights
- 4.1. Cell & Gene Therapy Bioanalytical Testing Services Market - Application Snapshot
- 4.2. Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Investments in Cell and Gene Therapy Developments Drive the Market Growth
- 4.2.1.2. Growing Development of Cell and Gene Therapies Drives Market Growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Stringent Regulations Hinders the Market Growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cell & Gene Therapy Bioanalytical Testing Services Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 5.3. Bioavailability & Bioequivalence Studies
- 5.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Bioavailability & Bioequivalence Studies, by Region, 2019-2032 (USD Million)
- 5.4. Pharmacokinetics
- 5.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Pharmacokinetics, by Region, 2019-2032 (USD Million)
- 5.5. Pharmacodynamics
- 5.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Pharmacodynamics, by Region, 2019-2032 (USD Million)
- 5.6. Others
- 5.6.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 6.3. Gene Therapy
- 6.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Gene Therapy, by Region, 2019-2032 (USD Million)
- 6.4. Gene-Modified Cell Therapy
- 6.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Gene-Modified Cell Therapy, by Region, 2019-2032 (USD Million)
- 6.5. Cell Therapy
- 6.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Cell Therapy, by Region, 2019-2032 (USD Million)
7. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 7.3. Nonclinical
- 7.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Nonclinical, by Region, 2019-2032 (USD Million)
- 7.4. Clinical
- 7.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Clinical, by Region, 2019-2032 (USD Million)
8. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 8.3. Infectious Diseases
- 8.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
- 8.4. Neurological disorders
- 8.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Neurological disorders, by Region, 2019-2032 (USD Million)
- 8.5. Oncology
- 8.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Oncology, by Region, 2019-2032 (USD Million)
- 8.6. Rare Diseases
- 8.6.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Rare Diseases, by Region, 2019-2032 (USD Million)
- 8.7. Others
- 8.7.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Others, by Region, 2019-2032 (USD Million)
9. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Cell & Gene Therapy Bioanalytical Testing Services Market Assessment, By Geography, 2019-2032 (USD Million)
- 9.3. Cell & Gene Therapy Bioanalytical Testing Services Market - North America
- 9.3.1. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.3.2. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.3.3. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.3.4. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.3.5. Cell & Gene Therapy Bioanalytical Testing Services Market - U.S.
- 9.3.5.1. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.3.5.2. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.3.5.3. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.3.5.4. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.3.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Canada
- 9.3.6.1. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.3.6.2. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.3.6.3. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.3.6.4. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4. Cell & Gene Therapy Bioanalytical Testing Services Market - Europe
- 9.4.1. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.2. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.3. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.4. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4.5. Cell & Gene Therapy Bioanalytical Testing Services Market - UK
- 9.4.5.1. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.5.2. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.5.3. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.5.4. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4.6. Cell & Gene Therapy Bioanalytical Testing Services Market - France
- 9.4.6.1. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.6.2. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.6.3. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.6.4. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Germany
- 9.4.7.1. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.7.2. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.7.3. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.7.4. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Italy
- 9.4.8.1. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.8.2. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.8.3. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.8.4. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Spain
- 9.4.9.1. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.9.2. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.9.3. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.9.4. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4.10. Cell & Gene Therapy Bioanalytical Testing Services Market - Netherlands
- 9.4.10.1. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.10.2. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.10.3. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.10.4. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4.11. Cell & Gene Therapy Bioanalytical Testing Services Market - Russia
- 9.4.11.1. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.11.2. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.11.3. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.11.4. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.4.12. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.4.12.2. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.4.12.3. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.4.12.4. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Asia Pacific
- 9.5.1. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5.5. Cell & Gene Therapy Bioanalytical Testing Services Market - China
- 9.5.5.1. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.5.2. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.5.3. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.5.4. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5.6. Cell & Gene Therapy Bioanalytical Testing Services Market - India
- 9.5.6.1. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.6.2. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.6.3. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.6.4. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Malaysia
- 9.5.7.1. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.7.2. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.7.3. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.7.4. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Japan
- 9.5.8.1. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.8.2. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.8.3. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.8.4. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Indonesia
- 9.5.9.1. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.9.2. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.9.3. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.9.4. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5.10. Cell & Gene Therapy Bioanalytical Testing Services Market - South Korea
- 9.5.10.1. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.10.2. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.10.3. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.10.4. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5.11. Cell & Gene Therapy Bioanalytical Testing Services Market - Australia
- 9.5.11.1. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.11.2. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.11.3. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.11.4. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.5.12. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.5.12.2. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.5.12.3. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.5.12.4. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.6.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.6.5.2. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.6.5.3. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.6.5.4. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.6.6. Cell & Gene Therapy Bioanalytical Testing Services Market - UAE
- 9.6.6.1. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.6.6.2. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.6.6.3. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.6.6.4. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.6.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Israel
- 9.6.7.1. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.6.7.2. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.6.7.3. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.6.7.4. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.6.8. Cell & Gene Therapy Bioanalytical Testing Services Market - South Africa
- 9.6.8.1. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.6.8.2. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.6.8.3. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.6.8.4. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.6.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.6.9.2. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.6.9.3. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.6.9.4. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Latin America
- 9.7.1. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.7.2. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.7.3. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.7.4. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.7.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Mexico
- 9.7.5.1. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.7.5.2. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.7.5.3. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.7.5.4. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.7.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Brazil
- 9.7.6.1. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.7.6.2. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.7.6.3. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.7.6.4. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.7.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Argentina
- 9.7.7.1. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.7.7.2. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.7.7.3. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.7.7.4. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
- 9.7.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
- 9.7.8.2. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
- 9.7.8.3. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
- 9.7.8.4. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. BioAgilytix Labs
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Charles River Laboratories
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Intertek Group Plc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. IQVIA, Inc.
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. KCAS Bioanalytical Services
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Laboratory Corporation of America Holdings
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Pharmaron
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Pharmaceutical Product Development, Inc.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Prolytix
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. SGS SA
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Syneos Health
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
샘플 요청 목록